Rob Miller has 17 years of biopharma commercial experience with Lilly, Abbott and AbbVie that provides the PAASP US team with an in-depth understanding of how future PAASP biopharma customers develop risk-adjusted valuations for both internal and external innovation:
- New product commercial development and for over 40 neuroscience programs
- Commercial forecasts and valuations for over 25 licensing/acquisition assessments
- Market research projects with over 1,500 HCPs, 300 patients and 250 payers
Rob’s commercial experience also includes seven years of medical product sales and account management with Baxter Healthcare plus account-based consulting and sales with health information firm Sachs Group / Solucient. As a Regional Director Rob managed licensing agreements with large US health systems and academic medical centers. Account based sales and licensing agreements will be directly relevant for building the US PAASP customer base and generating revenue.
Rob is currently Vice President, Strategic Initiatives, with Thresholds, which is a behavioral health service provider based in Chicago. Thresholds generates over $90 million in annual revenue and Rob is responsible for leading initiatives to diversify and grow revenue beyond state Medicaid including Substance Use Disorders and programs for early psychosis and young adults with an SMI diagnosis.